Treatment Of Patients With Social Anxiety Disorder
| Status: | Completed |
|---|---|
| Conditions: | Anxiety, Healthy Studies, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology, Other |
| Healthy: | No |
| Age Range: | 18 - 64 |
| Updated: | 10/14/2017 |
| Start Date: | November 9, 2006 |
| End Date: | September 5, 2007 |
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
GW876008 is a drug which may change mans reaction to stress, by decreasing the fear, physical
and behavior symptoms that people with SocAD experience in social situations.
and behavior symptoms that people with SocAD experience in social situations.
Inclusion criteria:
- are diagnosed with generalized social anxiety disorder/social phobia.
Exclusion criteria:
- have a diagnosis of major depressive disorder
- have a history of Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder.
We found this trial at
13
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials